Trial Profile
Non-Interventional Clinical Study to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia, Treated With Atypical Antipsychotics.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Oct 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 13 Oct 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 13 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2010 Actual initiation date changed from Jan 2009 to Feb 2009 as reported by ClinicalTrials.gov.